Detalhe da pesquisa
1.
A randomized phase 2 trial of nivolumab, gemcitabine, and cisplatin or nivolumab and ipilimumab in previously untreated advanced biliary cancer: BilT-01.
Cancer
; 128(19): 3523-3530, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35895381
2.
KRAS Mutation Variants and Co-occurring PI3K Pathway Alterations Impact Survival for Patients with Pancreatic Ductal Adenocarcinomas.
Oncologist
; 27(12): 1025-1033, 2022 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36124727
3.
Multiplex Enrichment and Detection of Rare KRAS Mutations in Liquid Biopsy Samples using Digital Droplet Pre-Amplification.
Anal Chem
; 91(12): 7516-7523, 2019 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-31072097
4.
Irinotecan-associated dysarthria: A single institution case series with management implications in patients with gastrointestinal malignancies.
J Oncol Pharm Pract
; 25(4): 980-986, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29562843
5.
A phase I trial of cabozantinib and gemcitabine in advanced pancreatic cancer.
Invest New Drugs
; 34(6): 733-739, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27439894
6.
BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study.
Genet Med
; 17(7): 569-77, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25356972
7.
The role of molecular testing in pancreatic cancer.
Therap Adv Gastroenterol
; 16: 17562848231171456, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37197396
8.
The GIANT trial (ECOG-ACRIN EA2186) methods paper: A randomized phase II study of gemcitabine and nab-paclitaxel compared with 5-fluorouracil, leucovorin, and liposomal irinotecan in older patients with treatment-naïve metastatic pancreatic cancer - defining a new treatment option for older vulnerable patients.
J Geriatr Oncol
; 14(3): 101474, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36963200
9.
Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04).
Clin Cancer Res
; 29(13): 2394-2400, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37115501
10.
Perioperative Chemotherapy and Chemoradiotherapy for Patients With Resectable and Borderline Resectable Pancreatic Adenocarcinoma.
Pancreas
; 52(5): e282-e287, 2023 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37782886
11.
Use of acupuncture with acupressure in addition to standard-of-care cryotherapy to decrease chemotherapy-associated neuropathy in patients with gastrointestinal malignancies receiving oxaliplatin-based chemotherapy: Study protocol for a randomized, controlled pilot and feasibility study.
Contemp Clin Trials
; 131: 107273, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37380021
12.
Combination immunotherapy for pancreatic cancer: challenges and future considerations.
Expert Rev Clin Immunol
; 18(11): 1173-1186, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36045547
13.
Biomarker-driven and molecularly targeted therapies for pancreatic adenocarcinoma.
Semin Oncol
; 45(3): 107-115, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30391013
14.
Metformin Use and Survival of Patients With Pancreatic Cancer: A Cautionary Lesson.
J Clin Oncol
; 34(16): 1898-904, 2016 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27069086
15.
DNA Damage Repair Defects and Survival Outcomes for Patients With Resected Pancreatic Ductal Adenocarcinoma.
Pancreas
; 50(5): e50-e52, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34106577
16.
Hereditary ATTR amyloidosis: a single-institution experience with 266 patients.
Amyloid
; 22(2): 123-31, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26017327
17.
Treatment of Cholesterol Embolization Syndrome in the Setting of an Acute Indication for Anticoagulation Therapy.
J Med Cases
; 5(6): 376-379, 2014 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25197328